Clinical Trials Logo

Recurrent Uterine Corpus Cancer clinical trials

View clinical trials related to Recurrent Uterine Corpus Cancer.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT02059265 Terminated - Clinical trials for Recurrent Ovarian Carcinoma

Dasatinib in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, Endometrial or Peritoneal Cancer

Start date: February 14, 2014
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well dasatinib works in treating patients with ovarian, fallopian tube, endometrial, or peritoneal cancer that has come back or is persistent. Dasatinib may shrink patients' tumors by blocking some of the enzymes needed for cell growth.